Giada Crescioli
Giada Crescioli is an expert in Pharmacy at University of Florence (Italy). Giada Crescioli has authored 83 publications, the most recent in 2026. SLR score: 229 (community average: 125). How the SLR is computed.
LeadR Profile
Pharmacy
Subspecialties: Public Health - Immunology - Neurology
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2016 - 2026
Number : 83
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Serum benzylpenicillin levels during treatment for amatoxin poisoning: pharmacokinetic support for OATP1B3 inhibition. PMID 42396640 — serum, poisoning, penicillin g, toxicology, therapeutics, poisons, pharmacokinetics | Clin Toxicol (Phila) | 2026 | 0 |
| Biosimilars in allergology: an outline in pediatric patients. PMID 42348641 — hypersensitivity, pharmacology, therapeutics, pediatrics, biosimilar pharmaceuticals | Curr Opin Allergy Clin Immunol | 2026 | 0 |
| Safety of co-administration of injectable vaccines in individuals under 18 years of age: A systematic literature review. PMID 41335471 — injections, immunization, safety, vaccines, vaccination, drug-related side effects and adverse reactions, adolescent, child | Hum Vaccin Immunother | 2025 | 0 |
| Epinephrine nasal spray for the treatment of anaphylaxis: perspectives in pediatrics. PMID 40971222 — hypersensitivity, anaphylaxis, epinephrine, pharmacology, nasal sprays, therapeutics, pediatrics, needles | Curr Opin Allergy Clin Immunol | 2025 | 0 |
| Safety of direct oral anticoagulants reversal agents in older patients: an analysis of individual case safety reports of adverse drug reaction from VigiBase ®. PMID 40192996 — anticoagulants, safety, pharmaceutical preparations, probability, aging, drug-related side effects and adverse reactions, demography, direct-acting oral anticoagulants | Aging Clin Exp Res | 2025 | 2 |
LeadR Networks
Main global connection map